PACS Group, Inc. (PACS)
NYSE: PACS · Real-Time Price · USD
10.58
-0.02 (-0.19%)
May 9, 2025, 11:24 AM - Market open
PACS Group Employees
PACS Group had 32,433 employees as of December 31, 2023.
Employees
32,433
Change
n/a
Growth
n/a
Revenue / Employee
$109,732
Profits / Employee
$2,845
Market Cap
1.64B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 32,433 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
Eli Lilly and Company | 47,000 |
PACS News
- 1 day ago - Bronstein, Gewirtz & Grossman, LLC Encourages PACS Group, Inc. (PACS) Stockholders to Inquire about Securities Investigation - Accesswire
- 3 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against PACS Group, Inc. (PACS) and Encourages Investors to Learn More About the Investigation - Accesswire
- 5 days ago - PACS Group, Inc. (PACS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Accesswire
- 8 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating PACS Group, Inc. (PACS) And Encourages Investors to Connect - Accesswire
- 10 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against PACS Group, Inc. (PACS) and Encourages Stockholders to Learn More About the Investigation - Accesswire
- 15 days ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against PACS Group, Inc. (PACS) And Encourages Investors to Reach Out - Accesswire
- 17 days ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against PACS Group, Inc. (PACS) And Encourages Stockholders to Reach Out - Accesswire
- 19 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating PACS Group, Inc. (PACS) And Encourages Stockholders to Connect - Accesswire